Cargando…
A genomic case study of mixed fibrolamellar hepatocellular carcinoma
BACKGROUND: Mixed fibrolamellar hepatocellular carcinoma (mFL-HCC) is a rare liver tumor defined by the presence of both pure FL-HCC and conventional HCC components, represents up to 25% of cases of FL-HCC, and has been associated with worse prognosis. Recent genomic characterization of pure FL-HCC...
Autores principales: | Griffith, O. L., Griffith, M., Krysiak, K., Magrini, V., Ramu, A., Skidmore, Z. L., Kunisaki, J., Austin, R., McGrath, S., Zhang, J., Demeter, R., Graves, T., Eldred, J. M., Walker, J., Larson, D. E., Maher, C. A., Lin, Y., Chapman, W., Mahadevan, A., Miksad, R., Nasser, I., Hanto, D. W., Mardis, E. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880064/ https://www.ncbi.nlm.nih.gov/pubmed/27029710 http://dx.doi.org/10.1093/annonc/mdw135 |
Ejemplares similares
-
A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML
por: Krysiak, K, et al.
Publicado: (2016) -
DGIdb 2.0: mining clinically relevant drug–gene interactions
por: Wagner, Alex H., et al.
Publicado: (2016) -
Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
por: Chen, Krista Y., et al.
Publicado: (2022) -
Radiotherapy for Metastatic Fibrolamellar Hepatocellular Carcinoma
por: G. Peacock, Justin, et al.
Publicado: (2013) -
Infrequent chromosome allele loss in fibrolamellar carcinoma.
por: Ding, S. F., et al.
Publicado: (1993)